Reporter
-
June 23, 2016
Drug monitoring programs reduce opioid deaths: study
The implementation of state prescription drug monitoring programs was associated with the prevention of approximately one opioid-related overdose death every two hours on average nationwide, according to a new Vanderbilt-led study released this week in the journal "Health Affairs." -
June 23, 2016
Girl’s dual heart, kidney transplants a VUMC first
Vanderbilt University Medical Center recently performed its first pediatric dual heart/kidney transplant on a 13-year-old girl from Chattanooga. -
June 23, 2016
‘Catalyst for Change’ event highlights clinical initiatives
Mitch Edgeworth, MBA, CEO of Vanderbilt University Adult Hospital and Clinics, brought his senior leadership team to three locations on June 17 for an annual update of initiatives and successes. -
June 23, 2016
Baby+Company celebrates 100th delivery milestone
Margaret Buxton, DNP, CNM, clinical director of the Nashville Baby+Company, could not have planned it any better if she tried. -
June 23, 2016
VU takes key role in cancer drug discovery consortium
Vanderbilt University has been selected as one of seven Dedicated Centers in the nation for the next phase of the Chemical Biology Consortium (CBC), a national network of scientists on the leading edge of cancer drug discovery. -
June 23, 2016
Mississippi family finds joy in giving back to VUMC
When the Pharr family wears Vanderbilt regalia around their Mississippi town, people often say, “I thought you were Ole Miss people.” -
June 23, 2016
Goldenring recognized for research mentorship efforts
James Goldenring, M.D., Ph.D., co-director of the Epithelial Biology Center at Vanderbilt University Medical Center (VUMC), has received a Research Mentor Award from the American Gastroenterology Association Institute Council for “outstanding research mentorship.”